Cargando…

Prevalence of metabolic syndrome among newly diagnosed hypertensive patients in the hills of Himachal Pradesh, India

To study the prevalence of metabolic syndrome (MS) among newly diagnosed hypertensive patients in a tertiary care hospital in the northern hilly state of Himachal Pradesh, India, located in western Himalayas at a moderate altitude of 2200 m above mean sea level. One hundred and eighteen newly diagno...

Descripción completa

Detalles Bibliográficos
Autores principales: Thakur, Surender, Raina, Sujeet, Thakur, Surinder, Negi, Prakash C., Verma, Balbir S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Medknow Publications & Media Pvt Ltd 2013
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3743377/
https://www.ncbi.nlm.nih.gov/pubmed/23961493
http://dx.doi.org/10.4103/2230-8210.113768
_version_ 1782280487124860928
author Thakur, Surender
Raina, Sujeet
Thakur, Surinder
Negi, Prakash C.
Verma, Balbir S.
author_facet Thakur, Surender
Raina, Sujeet
Thakur, Surinder
Negi, Prakash C.
Verma, Balbir S.
author_sort Thakur, Surender
collection PubMed
description To study the prevalence of metabolic syndrome (MS) among newly diagnosed hypertensive patients in a tertiary care hospital in the northern hilly state of Himachal Pradesh, India, located in western Himalayas at a moderate altitude of 2200 m above mean sea level. One hundred and eighteen newly diagnosed hypertensive patients above the age of 20 years were studied in a hospital-based cross-sectional study. MS prevalence was estimated by International Diabetes Federation (IDF) criteria and modified National Cholesterol Education Program-Adult Treatment Panel III (NCEP-ATP III) criteria. Student's t-test was used to compare the mean of the continuous variables. Chi-square test was used to compare discrete variables. The prevalence of MS in hypertensive patients was 68.6% (modified NCEP-ATP III) and 63.6% (IDF criteria). The most common phenotype of MS with the component of hypertension was the coexistence of waist circumference (90.1%), low high-density lipoprotein (HDL; 70.4%), and high triglycerides (67.9%) as per the modified NCEP-ATP III criteria, and low HDL (76.2%) and high triglycerides (66.4%) as per the IDF criteria. Fasting blood glucose (33.2% as per the modified NCEP-ATP III criteria and 32.6% as per the IDF criteria) was the least significant factor having an association with MS. The prevalence of MS among hypertensive patients was high and indicates the need for metabolic screening in all hypertensive patients at the first diagnosis.
format Online
Article
Text
id pubmed-3743377
institution National Center for Biotechnology Information
language English
publishDate 2013
publisher Medknow Publications & Media Pvt Ltd
record_format MEDLINE/PubMed
spelling pubmed-37433772013-08-19 Prevalence of metabolic syndrome among newly diagnosed hypertensive patients in the hills of Himachal Pradesh, India Thakur, Surender Raina, Sujeet Thakur, Surinder Negi, Prakash C. Verma, Balbir S. Indian J Endocrinol Metab Brief Communication To study the prevalence of metabolic syndrome (MS) among newly diagnosed hypertensive patients in a tertiary care hospital in the northern hilly state of Himachal Pradesh, India, located in western Himalayas at a moderate altitude of 2200 m above mean sea level. One hundred and eighteen newly diagnosed hypertensive patients above the age of 20 years were studied in a hospital-based cross-sectional study. MS prevalence was estimated by International Diabetes Federation (IDF) criteria and modified National Cholesterol Education Program-Adult Treatment Panel III (NCEP-ATP III) criteria. Student's t-test was used to compare the mean of the continuous variables. Chi-square test was used to compare discrete variables. The prevalence of MS in hypertensive patients was 68.6% (modified NCEP-ATP III) and 63.6% (IDF criteria). The most common phenotype of MS with the component of hypertension was the coexistence of waist circumference (90.1%), low high-density lipoprotein (HDL; 70.4%), and high triglycerides (67.9%) as per the modified NCEP-ATP III criteria, and low HDL (76.2%) and high triglycerides (66.4%) as per the IDF criteria. Fasting blood glucose (33.2% as per the modified NCEP-ATP III criteria and 32.6% as per the IDF criteria) was the least significant factor having an association with MS. The prevalence of MS among hypertensive patients was high and indicates the need for metabolic screening in all hypertensive patients at the first diagnosis. Medknow Publications & Media Pvt Ltd 2013 /pmc/articles/PMC3743377/ /pubmed/23961493 http://dx.doi.org/10.4103/2230-8210.113768 Text en Copyright: © Indian Journal of Endocrinology and Metabolism http://creativecommons.org/licenses/by-nc-sa/3.0 This is an open-access article distributed under the terms of the Creative Commons Attribution-Noncommercial-Share Alike 3.0 Unported, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Brief Communication
Thakur, Surender
Raina, Sujeet
Thakur, Surinder
Negi, Prakash C.
Verma, Balbir S.
Prevalence of metabolic syndrome among newly diagnosed hypertensive patients in the hills of Himachal Pradesh, India
title Prevalence of metabolic syndrome among newly diagnosed hypertensive patients in the hills of Himachal Pradesh, India
title_full Prevalence of metabolic syndrome among newly diagnosed hypertensive patients in the hills of Himachal Pradesh, India
title_fullStr Prevalence of metabolic syndrome among newly diagnosed hypertensive patients in the hills of Himachal Pradesh, India
title_full_unstemmed Prevalence of metabolic syndrome among newly diagnosed hypertensive patients in the hills of Himachal Pradesh, India
title_short Prevalence of metabolic syndrome among newly diagnosed hypertensive patients in the hills of Himachal Pradesh, India
title_sort prevalence of metabolic syndrome among newly diagnosed hypertensive patients in the hills of himachal pradesh, india
topic Brief Communication
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3743377/
https://www.ncbi.nlm.nih.gov/pubmed/23961493
http://dx.doi.org/10.4103/2230-8210.113768
work_keys_str_mv AT thakursurender prevalenceofmetabolicsyndromeamongnewlydiagnosedhypertensivepatientsinthehillsofhimachalpradeshindia
AT rainasujeet prevalenceofmetabolicsyndromeamongnewlydiagnosedhypertensivepatientsinthehillsofhimachalpradeshindia
AT thakursurinder prevalenceofmetabolicsyndromeamongnewlydiagnosedhypertensivepatientsinthehillsofhimachalpradeshindia
AT negiprakashc prevalenceofmetabolicsyndromeamongnewlydiagnosedhypertensivepatientsinthehillsofhimachalpradeshindia
AT vermabalbirs prevalenceofmetabolicsyndromeamongnewlydiagnosedhypertensivepatientsinthehillsofhimachalpradeshindia